Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) can disrupt menstrual cycles, and some people on it do find their period stops or becomes irregular. That is real, and it deserves a straight answer. What it is not, in most cases, is a direct pharmacological effect of the medicine itself — and that distinction matters. These are prescription-only medicines reviewed by a clinician before they are dispensed; if your cycle has changed significantly while on treatment, that is precisely the sort of thing to raise with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common assumption is that tirzepatide is acting on the reproductive system. It isn't, not directly. Mounjaro's licensed mechanism works through GIP and GLP-1 receptors involved in appetite regulation, insulin response and gastric emptying. There are no GLP-1 or GIP receptors in the uterine lining driving menstruation, and the medicine's Summary of Product Characteristics lists menstrual irregularity as a reported side effect without describing it as a direct pharmacological action.
What is actually happening in most cases is that rapid, significant weight loss (the kind tirzepatide produces) is a well-established trigger for menstrual disruption. Fat tissue is hormonally active. It synthesises oestrogen, influences leptin and sex-hormone-binding globulin, and plays a direct role in regulating the hypothalamic-pituitary-ovarian axis. Lose a meaningful amount of body fat quickly and that axis notices. The result can be lighter periods, missed cycles, or a temporary stop. This happens with caloric restriction alone; tirzepatide accelerates the process, so the disruption can be more pronounced and arrive faster than it might otherwise. You can read more about the medicine's licensed mechanism on the tirzepatide overview page.
The practical upshot: if your period has stopped on Mounjaro, the most likely explanation is the weight loss itself, not a specific toxic effect of the drug.
Irregular cycles can create a false sense of security around contraception. Ovulation does not reliably stop before menstruation does. Someone whose periods have become erratic on tirzepatide may still be ovulating unpredictably, which means pregnancy is possible even when a period hasn't arrived for weeks.
There is a separate reason to think carefully about contraception on Mounjaro. The NHS advises that women taking oral contraceptives should add a non-oral method (condoms, for instance) for the first four weeks of tirzepatide treatment and for four weeks after each dose increase, because tirzepatide's effect on gastric emptying may reduce how reliably the pill is absorbed. Semaglutide does not carry an equivalent advisory. This is one of those things that gets lost in the excitement of starting treatment, and it matters. NHS guidance on weight-management injections covers this clearly.
Beyond contraception, a stopped period that persists for more than two or three cycles warrants a GP visit regardless of the cause. Prolonged amenorrhoea can affect bone density over time and may signal that caloric restriction has gone further than is sustainable. If you are unsure whether what you are experiencing is within normal range, our team is available through aftercare support seven days a week.
For most people, menstrual disruption related to weight loss is temporary. As the rate of weight change slows (usually once a maintenance dose is established and the body has adjusted) cycles tend to settle, and you can find more detail about what to expect during this phase on our page covering the Mounjaro stopping period. This mirrors what is seen in people recovering from rapid weight loss through other means: the hypothalamic-pituitary-ovarian axis recalibrates once it reads a more stable energy environment.
Some people find their cycle actually becomes more regular on tirzepatide than it was before, particularly those with polycystic ovary syndrome. PCOS is closely linked to insulin resistance and elevated androgens; as insulin sensitivity improves and body fat decreases, the hormonal imbalance underpinning the condition often eases. Regular periods returning after years of irregular ones is a reported experience in this group, though it is not guaranteed and should not be assumed without medical assessment.
A cycle that does not return after several months, or one accompanied by other symptoms (hot flushes, significant pelvic pain, unexpected discharge), should be investigated properly. The NHS tirzepatide medicines page lists changes to period regularity among the reported effects worth discussing with a clinician. Our detailed page on Mounjaro and periods covers PCOS, fertility and cycle changes at greater length if you want to read further.
First, rule out pregnancy. That is not alarmist, it is the most important step when any period is late, regardless of what else might explain it. Over-the-counter tests are reliable; if there is any doubt, speak to your GP.
Second, let your prescriber know. Menstrual changes are clinically relevant information. If you are a patient with a current prescription, note it at your next review. If the change is significant or you are worried now, do not wait. Prescribers at regulated pharmacies (the kind you can verify on the GPhC register) are there between reviews precisely for situations like this.
Third, revisit your nutrition. Rapid weight loss is more likely to disrupt cycles when protein and calorie intake drops sharply. GLP-1 and dual-agonist medicines reduce appetite significantly; some patients eat far less than they realise and undermine the hormonal environment needed for a regular cycle. A conversation with a dietitian alongside your medical team is often more useful than adjusting the dose. If you are thinking about what happens when weight loss plateaus, nutrition is part of that picture too.
Finally, keep records. Note when your last period was, how it differed from your usual pattern, and when you started or increased your dose. That information makes any clinical assessment much faster, and patients based locally may find it useful to explore the support options on our Mounjaro Coventry page. When you are ready to talk to our prescribers, checking your eligibility takes a few minutes and every consultation is reviewed by a real clinician the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.